Uncategorized
Leading BioSciences Teams with Donnelley Financial Solutions to Create Innovative Study Tool for Clinical Trial Monitoring During COVID-19 Pandemic
SAN FRANCISCO--(BUSINESS WIRE)--Donnelley Financial Solutions (NYSE: DFIN), a leading risk and compliance company, today announced that Leading BioSciences, Inc. (LBS), a drug development company focused on improving human health through therapeutic protection of the intestinal mucosal barrier, is working with DFIN to manage remote monitoring of their COVID-19 study. LBS is taking a unique approach to investigating treatments for COVID-19 by targeting gut integrity as a potential method of disr